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Abstract: The purpose of this study was to assess the induced apoptosis of self-assembled iron 
oxide magnetic nanoparticles (MNPs) co-loaded with daunorubicin (DNR) and 5-bromotetrandrin 
(Br Tet) (DNR/Br Tet-MNPs), acting as a drug depot system for the sustained release of the 
loaded DNR and BrTet, in the drug resistant human leukemia K562/A02 cells and further to 
explore potential mechanisms. After being incubated for 48 hours, K562/A02 cells were treated 
with DNR/Br Tet-MNPs or DNR and Br Tet in solution (DNR/Br Tet-Sol). Morphologic char-
acteristics of K562/A02 cells were observed under a fluorescence microscope; cell apoptosis 
and intracellular accumulation of DNR were analyzed by FACS Calibur flow cytometry. 
  Furthermore, reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting 
analyses were performed to study the apoptosis associated gene transcription and protein expres-
sion, respectively. Typical apoptotic characteristics, including chromatin condensation and 
fragmentation of nuclei, were observed and a high rate of apoptosis was detected in 
K562/A02 cells treated with DNR/Br Tet-MNPs and DNR/Br Tet-Sol. Detection of relative 
fluorescence intensity of intracellular DNR demonstrated that intracellular DNR was higher in 
K562/A02 cells treated with DNR/Br Tet-MNPs than that of DNR/Br Tet-Sol. Further study 
demonstrated that both DNR/Br Tet-MNPs and DNR/Br Tet-Sol reduced the gene transcriptions 
and protein expressions of bcl-2 and survivin and enhanced that of bax and caspase 3. It is 
concluded that self-assembled DNR/Br Tet-MNPs, as one of the potential antitumor agents for 
hematologic malignancies, may effectively induce apoptosis of K562/A02 cells through elevat-
ing the ratio of bax/bcl-2, activating caspase 3, and inactivating survivin.
Keywords: magnetic iron oxide nanoparticles, daunorubicin, 5-bromotetrandrin, target therapy, 
multidrug resistance, apoptosis, K562/A02 cells
Introduction
Currently, serious toxicity and poor antitumor efficacy resulting from the induction of 
drug resistance in hematological malignancies and other tumors are common   hindrances 
to successful systemic chemotherapy.1 Combined use of reversal agents and antitumor 
agents to increase the antitumor effects, reduce dose-limiting side effects of chemotherapy 
agents, and reverse multidrug resistance (MDR) has shown potential achievements.2 
However, there is still a problem of how to ensure that two different agents with different 
pharmacokinetics and tissue disposition execute their effects simultaneously at the same 
organ. What is exciting is that a nanoparticle drug delivery system has shown potential 
in its application to carry drugs to target sites effectively.3–5 Moreover, it potentially International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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avoids damaging healthy cells when cancer cells are killed. 
Nowadays, nanosized iron oxide magnetic particles, mostly 
magnetite (Fe3O4) and maghemite (γ-Fe2O3), are widely used 
in biomedicine owing to their notable properties, such as super-
paramagnetism and biocompatibility.6 Previous research has 
shown that magnetic nanoparticles (MNPs) of Fe3O4 combined 
with daunorubicin (DNR) and 5-bromotetrandrine (Br Tet) 
displayed a significant cytotoxicity effect on drug resistant 
leukemia K562/A02 cells.7,8 However, the polymerization of 
MNPs with DNR and Br  Tet was by way of mechanical absorp-
tion, which meant that the binding of these three agents might 
not be so compact and that lots of drugs would be released 
before they reached the target site. To solve this problem, we 
  developed a novel DNR/Br Tet-MNPs formulation, magnetic 
iron oxide nanoparticles co-loaded with DNR and Br Tet. We 
used oleic acid-coated iron oxide nanoparticles as drug car-
riers, which were further modified by pluronic F-127. DNR 
and Br Tet were then permeated into the OA shell. It possessed 
high drug loading capacity and acted as a drug depot for the 
sustained release of drugs up to 25 days. To study its potential 
effect on hematologic malignancies, we evaluated the induced 
apoptosis of self-assembled DNR/Br Tet-MNPs formulation 
in human leukemia K562/A02 cells and further exploited the 
potential mechanisms.
Materials and methods
experimental agents
Iron chloride hexagydrate (FeCl3 ⋅ 6H2O) and iron sulfate hepta-
hydrate (FeSO4 ⋅ 7H2O) were from Sinopharm Chemical Reagent 
Co, Ltd (Shanghai, China). Ammonium hydroxide (NH4 ⋅ OH) 
and oleic acid (OA) were from Shanghai Lingfeng Chemical 
Reagent Co, Ltd (Shanghai, China). Pluronic® F-127 was from 
Sigma-Aldrich (San Diego, CA). Other reagents included 
Daunorubicin hydrochloride (Huifengda Chemical Co, Jinan, 
China), 5-bromotetrandrin (Kanghong Phamaceuticals Inc, 
Chengdu, China), RPMI 1640 medium (Gibco, Gaithersburg, 
MD), newborn bovine serum   (Sijiqing, Hangzhou, China), 
Adriamycin (Hisun Phamaceutical Co, Zhejiang, China), and 
4,6-diamidino-2- phenylindole (DAPI) staining solution (Beyo-
time Institute of Biotechnology, Jiangsu, China). RT-PCR kit was 
from Takara   Biotechnology (Dalian, China). Monoclonal anti-
bodies of bax, bcl-2, cleaved caspase 3, survivin, and GAPDH 
were from Santa Cruz Biotechnology (Santa Cruz, CA).
Preparation of DNr/Br Tet-MNPs
Aqueous dispersion of MNPs, OA-coated and   pluronic-stabilized 
iron-oxide nanoparticles, were prepared as previously 
described.9 The hydrophobic DNR or Br Tet solution were 
prepared by adding triethylamine into DNR hydrochloride or 
Br Tet hydrochloride methanolic solution,10 and a combina-
tion of DNR and Br Tet (1:1 w/w) were added dropwise into 
the above mentioned aqueous dispersion of MNPs and stirred 
vigorously on a magnetic stirring plate overnight to make the 
drug participate into OA layer.11 The total drug loading capac-
ity was 8.25%, and about 19% of DNR and 16% of Br Tet were 
released in the first 2 days. Interestingly, the drug loaded MNPs 
were able to release drugs persistently up to 25 days.
cell culture
Human chronic myeloid leukemia resistant cell line, 
adriamycin-selected K562/A02, was received as a gift from 
the Institute of Hematology, Chinese Academy of Medical 
  Sciences. Cells were cultured in RPMI 1640 medium with 
10% newborn bovine serum, 10 mM HEPES, 100 U/mL 
penicillin, and 100 µg/mL streptomycin at 37°C in a humidi-
fied 5% CO2 atmosphere. To maintain MDR phenotype, 
K562/A02 cells were cultured in the medium containing 
1 µg/mL adriamycin at least 1 week before experiments.
Morphologic characteristics  
of apoptosis by DAPI stain assay
After being cultured as above, cells were collected and 
smeared. Once fixed with methanol for 15 minutes, cells were 
stained with fluorochrome dye DAPI and then observed under 
a fluorescence microscope (IX51; Olympus, Tokyo, Japan) 
with a peak excitation wavelength of 340 nm.
Apoptosis assay by flow cytometry
4 × 105 K562/A02 cells were exposed to DNR alone in solution 
(DNR-Sol, 0.5 µg/mL), Br Tet alone in solution (Br Tet-Sol, 
0.5 µg/mL), combined DNR and Br Tet in solution (DNR/
Br Tet-Sol, total drug 1 µg/mL, DNR:Br Tet = 1:1 w/w), and 
DNR alone in MNPs (DNR-MNPs), Br Tet alone in MNPs (Br 
Tet-MNPs), or combined DNR and Br Tet in MNPs (DNR/Br 
Tet-MNPs) for 48 hours. Following two washes with phosphate-
buffered saline (pH = 7.4), cells were suspended with 500 µL 
of binding buffer and labeled with 5 µL of Annexin V-FITC 
for 15 minutes at room temperature in the dark. Thereafter, 
cell apoptosis was determined by flow cytometry (FCM) using 
CellQuest software (Becton Dickinson, Franklin Lakes, NJ) at 
excitation/emission wavelengths of 488/575 nm in 1 hour.
Intracellular accumulation of DNr  
by flow cytometry assay
Intracellular accumulation of DNR was directly detected 
by FCM.7 Briefly, the K562/A02 cells were treated as International Journal of Nanomedicine 2011:6
Table 1 summary of primer sequences for bcl-2, bax, caspase 3, survivin, and GAPDH
Gene Primer for RT-PCR Band size (bp) Annealing 
temperature (°C)
bcl-2 Forward 5′-TgTggccTTcTTTgAgTTcg-3′
reverse 5′-TcAcTTgTggcccAgATAgg-3′
281  56 
bax Forward 5′-TTTgcTTcAgggTTTcATcc-3′
reverse 5′-cAgTTgAAgTTgccgTcAgA-3′
246  52
caspase 3 Forward 5′-TTgATgcgTgATgTTTcTA-3′
reverse 5′-cAATgccAcAgTccAgTTc-3′
223 51
survivin Forward 5′-cTcAAggAccAccgcATcTc-3′
reverse 5′-ccTcAATccATggcAgccAg-3′
392 55
GAPDH Forward 5′-gccAcATcgcTcAgAcAc  -3′
reverse 5′-cATcAcgccAcAgTTTcc-3′
614 53
Abbreviation: rT-Pcr, reverse transcriptase polymerase chain reaction.
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  previously described. After being cultured for 48 hours, cells 
were washed three times with phosphate-buffered saline 
and then suspended with 500 µL of phosphate-buffered 
saline. Thereafter, each sample was measured by FCM 
at excitation/emission wavelengths of 488/575 nm. The 
relative fluorescence intensity (RFI) of DNR was calculated 
as FItreated group/FIcontrol group.
reverse transcriptase polymerase  
chain reaction (rT-Pcr) assay
The K562/A02 cells were treated as previously described for 
48 hours. Total RNA extraction was conducted with TRIzol 
and RT-PCR was performed according to manufacturer’s 
instructions. Briefly, total RNA (1 µg) of samples were added 
to RT buffer, 25 mM of MgCl2, 10 mM dNTPs, Random 
9 mers (50 pmol/µL), RNase inhibitor (40 U/µL), and AMV 
reverse transcriptase (5 U/µL) to provide a final total volume 
of 20 µL. The conditions of RT were 30°C for 10 minutes, 
42°C for 30 minutes, 99°C for 5 minutes, and 5°C for 
5   minutes. The newly synthesized cDNA was then amplified 
by PCR and the conditions were 94°C for 30 seconds, 56°C 
for 30 seconds, and 72°C for 1 minute. There were pre- 
denaturing at 94°C for 2 minutes and final extension at 72°C 
for 7 minutes. The designed PCR primers to amplify products 
within target and control sequences were listed in Table 1. 
The PCR products were visualized on a 1.5% agarose gels 
by ethidium bromide staining. For densitometric analysis, 
band intensity was assessed using ScnImage software (Scion 
Corporation, Frederick, MD). After band intensity was 
adjusted by GAPDH intensity, data were calculated as the 
mean ± standard deviation of at least three experiments.
Western blotting assay
Western blotting was performed as previously described.7 
Briefly, total protein was isolated from the harvested cells 
in 25 mM Tris-HCl (pH = 7.4), 150 mM NaCl, 1% Triton 
X-100, 5 mM EDTA, 5 mM EGTA, 10 mM NaF, 1 mM PMSF, 
0.5% NP-40, 10 µg/mL aprotinin, 10 µg/mL leupeptin, and 
1 mM pepstatin for 15 minutes at 4°C and then centrifuged 
at 10,000 rpm for 5 minutes. Samples containing 25 µg of 
protein were fractionated by 10% SDS-PAGE. The protein was 
transferred onto nitrocellulose filter (Bio-Rad, Hercules, CA) 
by electroblotting. Non-specific binding sites were blocked 
for 1 hour with 5% non-fat milk. Mouse monoclonal anti-
human bax (1:200), bcl-2 (1:200), cleaved caspase 3 (1:200), 
survivin, or GAPDH (1:400) antibodies were incubated to the 
membrane overnight at 4°C. Then a secondary horseradish 
peroxidase-labeled rabbit-mouse IgG (1:5000) was added 
and incubated for 1 hour at room temperature. The blots were 
visualized by densitometry scans (ECL system, Amersham, 
UK) according to manufacturer’s instruction.
statistical analysis
Accordingly, all the data were expressed as mean ± standard 
deviation. Statistical analyses comparing data between 
groups were performed using one-way analysis of variance 
(ANOVA) by means of Statistical Package for Social Science 
(version 13.0; SPSS Inc, Chicago, IL). A value of P , 0.05 
denoted statistical significance.
Results
Morphological characteristics  
of K562/A02 cells
The morphological characteristics of K562/A02 cells were 
detected by DAPI staining assay (Figure 1). The nuclei of 
K562/A02 cells in control group were stained widespread 
with steady and low intensity blue fluorescence, suggesting 
the chromatins were equably distributed in nuclei. However, 
those treated with combination of DNR and Br Tet in MNPs 
or in solution for 48 hours showed typical features of apop-
tosis, such as chromatin condensation, nucleolus pyknosis, 
and nuclear fragmentation.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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Apoptosis assay by flow cytometery
After incubation for 48 hours, the apoptotic rates of 
K562/A02 cells treated with medium, DNR-Sol, Br Tet-Sol, 
DNR/Br Tet-Sol, DNR-MNPs, Br Tet- MNPs, DNR/Br Tet-
MNPs, and MNPs were 4.94% ± 1.89%, 6.53% ± 4.05%, 
6.16% ± 1.99%, 44.02% ± 9.09%, 8.84% ± 6.45%, 
6.26% ± 4.39%, 24.60% ± 4.42%, and 3.85% ± 1.90%, 
respectively. Compared to control group, the apoptotic rates 
in DNR/Br Tet-MNPs group and DNR/Br Tet-Sol group 
significantly increased (P , 0.05), and in the DNR/Br Tet-
Sol group was higher than in the DNR/Br Tet-MNPs group 
(P , 0.05) (Figure 2).
enhancement of intracellular DNr 
accumulation with nanoparticle delivery
The RFI of DNR in K562/A02 cells incubated with DNR-
Sol, DNR/Br Tet-Sol, DNR-MNPs, and DNR/Br Tet-
MNPs were 9.84 ± 1.73, 16.75 ± 1.47, 14.36 ± 2.98, and 
25.97 ± 2.28, respectively. Compared to either DNR-Sol or 
DNR-MNPs, both DNR/Br Tet-Sol and DNR/Br Tet-MNPs 
significantly enhanced the intracellular DNR accumulation, 
AB C
Figure 1 The morphological characteristics of apoptosis in K562/A02 cells incubated 
for 48 hours. (DAPI staining, ×100). A) control; B) DNr/Br Tet-sol; C) DNr/Br Tet-
MNPs. Arrows indicate cells with apoptotic nuclear condensation and fragmentation.
Abbreviations: DNr/Br Tet-sol, daunorubicin and 5-bromotetrandrin in solution; 
DNr/Br Tet-MNPs, daunorubicin and 5-bromotetrandrin in magnetic nanoparticles.
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Figure 2 The apoptotic rates of K562/A02 cells incubated for 48 hours by flow cytometry assay. A) control; B) DNr-sol; C) Br Tet-sol; D) DNr/Br Tet-sol; E) DNr-
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respectively (P , 0.05). What’s more, the relative   fluorescence 
intensity of intracellular DNR demonstrated that intracellular 
DNR was higher in K562/A02 cells treated with DNR/Br Tet-
MNPs than that of DNR/Br Tet-Sol (P , 0.05) (Figure 3).
effects of DNr/Br Tet-MNPs on 
apoptosis-associated genes and proteins
When treated with DNR/Br Tet-MNPs or DNR/Br Tet-Sol 
for 48 hours, the levels of bcl-2 and survivin mRNA in K562/
A02 cells were both significantly down-regulated, while 
those of bax and caspase 3 mRNA were both up-regulated 
 ( Figure 4). Interestingly, the effects were further demon-
strated by the reduction of bcl-2 and survivin proteins, and 
the increase of bax and caspase 3 proteins in K562/A02 cells 
(Figure 5), suggesting that the relative ratio of bax/bcl-2 in 
these two groups increased significantly (P , 0.05) and in 
DNR/Br Tet-MNPs was slightly lower than that of DNR/
Br Tet-Sol. Meanwhile, the up-regulated levels of caspase 
3 mRNA and protein in DNR/Br Tet-MNPs group were a little 
lower than those in DNR/Br Tet-Sol group (P , 0.05), while 
the down-regulated levels of survivin mRNA and protein in 
the former were lower than those in the latter (P , 0.05). 
Unluckily, the above-mentioned apoptosis-related gene 
mRNA or protein were not obviously altered in other groups 
when compared to control group (P . 0.05).
Discussion
Owing to the MDR of tumor cells to conventional antitumor 
drugs, systemic chemotherapy in treatment of hematological 
malignancies is impeded.12 The mechanisms in the develop-
ment of MDR are complicated, including overexpression of 
transporter proteins such as P-gp, intracellular detoxifica-
tion by increased levels of glutathione, altered DNA repair, 
and failure to undergo apoptosis.13 Various reversal agents 
have been studied to overcome MDR, but the results are not 
satisfactory due to their dose-limiting toxicity.14,15 Previous 
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  studies demonstrate that Br Tet is an effective reversal agent 
of MDR in vitro and in vivo by inhibiting the overexpres-
sion of P-gp and increasing intracellular accumulation of 
anticancer drugs.16,17 Some reports displayed that one of the 
important mechanisms of tumorigenesis and resistance to 
anticancer drugs was blockade of the apoptosis-inducing 
pathway.18,19 To reverse MDR and minimize serious unde-
sired side effects of systemic chemotherapy, we have devel-
oped a promising DNR/Br Tet-MNPs formulation, and in this 
study, we focus on its effects on the induction of apoptosis 
in drug resistant human leukemia K562/A02 cells.
The morphology of K562/A02 cells treated with DNR/
Br Tet-MNPs shows chromatin condensation, nucleolus 
pyknosis, and nuclear fragmentation, which are typical char-
acteristics of apoptosis. The similar morphological changes 
are also observed in cells treated with DNR/Br Tet-Sol. 
Flow cytometric analysis shows that the cell apoptotic rate 
of K562/A02 cells treated with either DNR/Br Tet-MNPs 
or DNR/Br Tet-Sol is significantly different when compared 
to the control group, and the effect of DNR/Br Tet-MNPs is 
weaker than that of DNR/Br Tet-Sol, which may be related 
to the sustained release property of DNR/Br Tet-MNPs in 
the first 2 days of in vitro drug release study. But there is no 
obvious difference of cell apoptotic rates in cells treated with 
either DNR or Br Tet alone or combination with MNPs.
Fluorospectrophotometric assay shows that the intracellu-
lar DNR in DNR-MNPs group is higher than that in DNR-Sol 
group, which may be related to the ability of K562/A02 cells 
to take up nanoparticles with loaded DNR and thus reduce 
excretion by P-gp. Compared to DNR alone, the combina-
tion of DNR and Br Tet makes intracellular DNR increase 
prominently. Moreover, compared to DNR-MNPs, DNR and 
Br Tet co-loaded in MNPs significantly increase the intra-
cellular DNR. Meanwhile, we find that more accumulation 
of DNR in cells treated with DNR/Br Tet-MNPs than that 
with DNR/Br Tet-Sol. We consider there are three reasons 
to explain these phenomena: 1) the inhibition of released Br 
Tet from MNPs makes the cells reduce the excretion of DNR; 
2) a large proportion of DNR is still stored in MNPs for the 
property of sustained release, which is the reason why the 
rate of apoptosis in the DNR/Br Tet-MNPs group is lower 
than DNR/Br Tet-Sol; and 3) the underlying mechanism of 
nanoparticles entering cells is endocytotic and/or pinocy-
totic activity rather than a consequence of simple passive 
permeation.
In order to explore the potential mechanisms of our 
DNR/Br Tet-MNPs formulation, we have observed the 
alternation of some apoptosis-associated gene transcrip-
tion and protein expression. A large amount of evidence 
has shown that the sensitivity of cells to apoptotic stimuli International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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is determined by the relative ratio of pro-apoptotic and 
anti-apoptotic members of the bcl-2 family, which is the 
mitochondrial-related death switch.20 Bcl-2 is believed 
to promote tumorigenesis and prevent cells undergoing 
apoptosis, while bax is well known to initiate cell death 
by disrupting the integrity of the mitochondrial membrane 
and promoting release of cytochrome c from mitochon-
dria, resulting in caspase 9/caspase 3 activation and DNA 
fragmentation.21,22 Caspase 3, a key protease and activated 
during the early stages of apoptosis, is synthesized initially 
as an inactive pro-enzyme in cells undergoing apoptosis and 
then hydrolyzed by itself and/or cleaved by other   proteases.23 
In our study, the increased ratios of bax/bcl-2 are found in 
both DNR/Br Tet-MNPs and DNR/Br Tet-Sol. In addition, 
DNR/Br Tet-MNPs obviously raise the level of caspase 
3 mRNA and protein, inferring their facilitative effect on 
caspase 3 activation. Survivin is a member of the inhibitor 
of apoptosis protein family and expresses specifically dur-
ing embryogenesis and in tumor cells and suppresses cell 
death signaling.24 Our DNR/Br Tet-MNPs formulation also 
displays the significant down-regulation of survivin mRNA 
and protein in K562/A02 cells. Similarly, the effects of 
DNR/Br Tet-MNPs are less than that of DNR/Br Tet-Sol as 
a result of the sustained release property.   Collectively, DNR/
Br Tet-MNPs have shown to dramatically elevate bax/bcl-2 
ratio, enhance caspase 3 activities, and further stimulate the 
initiation of mitochondrial apoptosis signaling, and inhibit 
the expression of survivin.
Conclusion
The current in vitro study indicates that self-assembled 
DNR/Br Tet-MNPs formulation induces apoptosis in drug 
resistant K562/A02 cells by elevating the ratio of bax/bcl-2, 
activating caspase 3, and inhibiting survivin. These findings 
further support that DNR/Br Tet-MNPs formulation may be 
a potential application as an antitumor agent in the treatment 
of hematologic malignancies.
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